These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 572939)

  • 1. Sinemet and thyroid function in Parkinson disease.
    Wingert TD; Hershman JM
    Neurology; 1979 Jul; 29(7):1073-4. PubMed ID: 572939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function in Parkinson disease.
    Berger JR; Kelley RE
    Neurology; 1981 Jan; 31(1):93-5. PubMed ID: 7192833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
    Goetz CG; Tanner CM; Klawans HL; Shannon KM; Carroll VS
    Neurology; 1987 May; 37(5):875-8. PubMed ID: 3574696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusions of thyrotropin releasing hormone.
    Harman SM; Wehmann RE; Blackman MR
    J Clin Endocrinol Metab; 1984 Feb; 58(2):320-6. PubMed ID: 6420436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinemet-ferrous sulphate interaction in patients with Parkinson's disease.
    Campbell NR; Rankine D; Goodridge AE; Hasinoff BB; Kara M
    Br J Clin Pharmacol; 1990 Oct; 30(4):599-605. PubMed ID: 2291872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100).
    Cedarbaum JM; Kutt H; McDowell FH
    Neurology; 1989 Nov; 39(11 Suppl 2):38-44; discussion 59. PubMed ID: 2586762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familiar thyroxine-binding globulin deficiency.
    Konno N
    Endocrinol Jpn; 1976 Aug; 23(4):313-7. PubMed ID: 828576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pituitary-thyroid axis in patients with pituitary disorders.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1989 Jul; 21(7):387-90. PubMed ID: 2506120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
    Diamond SG; Markham CH; Treciokas LJ
    Ann Neurol; 1978 Mar; 3(3):267-72. PubMed ID: 352236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levodopa on thyroid function and prolactin release. A study in patients with Parkinson's disease.
    Lavin PJ; Gawel MJ; Das PK; Alaghband-Zadeh J; Rose FC
    Arch Neurol; 1981 Dec; 38(12):759-60. PubMed ID: 6797388
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations.
    Jankovic J; Schwartz K; Vander Linden C
    Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
    Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC
    Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease.
    Leibowitz M; Lieberman A
    Neurology; 1975 Oct; 25(10):917-21. PubMed ID: 52131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective thyroidal iodine concentration in protein-calorie malnutrition.
    Gaitan JE; Mayoral LG; Gaitan E
    J Clin Endocrinol Metab; 1983 Aug; 57(2):327-33. PubMed ID: 6408112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression.
    Lewis GF; Alessi CA; Imperial JG; Refetoff S
    J Clin Endocrinol Metab; 1991 Oct; 73(4):843-9. PubMed ID: 1653784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
    Wenzel KW
    Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familial thyroxine-binding globulin deficiency.
    Konno N
    Endocrinol Jpn; 1977 Aug; 23(4):313-7. PubMed ID: 72658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.